The 6:00 brief

The 6:00
brief

A calm weekly email for people who read the methods section. New research, rule changes and lab literacy, with the sources linked.

The 6AM mark rendered in glass
Short answerStandards & trust · 4 min read · Updated 17 Nov 2026

The 6:00 brief is 6AM's free email, sent once a week on Sunday. It explains new peptide research in plain English, tracks regulatory changes in the US, UK and Australia, and teaches how to read lab reports. It never carries prices, sales or amounts for use in people, and you can unsubscribe in one click.

Key takeaways

  • One email a week, on Sunday evening (US Eastern time).
  • New research explained, regulatory changes with primary sources, lab literacy and reader questions.
  • Never prices, offers, store links, amounts for people or testimonials.
  • Opt-in only: you confirm by email, and one click unsubscribes you, and we act on it promptly.

01What each issue contains

One email, from the desk that writes this site, with the sources linked.

  • New research, explained. A recent paper in plain English: the model (cell, animal or human), the sample size, what was measured, what it does not show and its evidence grade.
  • Regulatory changes. What changed at the FDA, HHS, the MHRA, the TGA or WADA, with the date and a link to the regulator's own document. Rule changes are also logged in our regulatory changelog.
  • Lab literacy. How to read a lab report, what a test method can and cannot show, and claims we checked against the study they cite.
  • Reader questions. Questions from readers and the community, answered by 6AM Research.
  • New batch reports. One line for each new 6AM lab report, linked to the batch lookup. No prices, no product claims.

02What it never contains

  • Prices, offers, promotional codes or links to a store.
  • Amounts, schedules or instructions for use in people. Our reasons are on why we never give amounts.
  • Before-and-after stories, or testimonials about results.
  • Countdowns, "last chance" lines or anything written to rush you.
  • Personal health advice. If you write to us about your health, we will point you to a clinician who knows you.

The brief follows the same editorial policy as every page on this site: each claim about a compound is tied to its source and its evidence grade, and we say where the research stops.

03How often it arrives

Once a week, on Sunday evening (US Eastern time). One email, short enough to read with a coffee.

After you confirm, you also get a short welcome series that explains how we read lab reports and how we grade evidence. Then the weekly rhythm starts.

If we ever add a more frequent email, it will be a separate list that you choose to join. Signing up here will never put you on it.

[First issue date: confirm before launch.]

04Sign up

[PREVIEW: this form is not connected yet; nothing is sent.]

05Consent and unsubscribing, in plain words

1
You ask

Enter your email address. The only thing we send at this point is a confirmation email.

2
You confirm

Click the link in that email. Until you do, you are not on the list and nothing else arrives.

3
We keep a record

We record what you agreed to, when, and the page you signed up from, so we can show that you asked. Only we and the service providers that run the site and send the brief for us can see your address. See the privacy policy.

4
You can leave at any time

Every email has an unsubscribe link at the bottom. One click, no login, no questions. We stop promptly.

5
We check in if you go quiet

If several months pass without a single click, we ask once whether you still want the brief. If you don't answer, we stop sending it.

Every email says who sent it and carries our postal address. [ADDRESS: confirm before launch.]

New readers also get one separate note about how membership works, and can stop it without leaving the brief.

06Why we use the strictest rule for everyone

The brief is written for readers in the US, the UK and Australia, and the three countries set different rules. Rather than split the list, we apply the strictest version to everyone.

CountryWhat the rule requiresPrimary source
UKMarketing emails to individuals need the person's prior consent. The "soft opt-in" exception only covers people whose details were collected during a sale or negotiation.Privacy and Electronic Communications Regulations 2003, regulation 22
AustraliaCommercial emails need consent, and every message needs an unsubscribe option that is honoured within 5 working days.Spam Act 2003, as explained by the ACMA
USOpt-out requests must be honoured within 10 business days, and every message must include a valid postal address.CAN-SPAM Act, as explained by the FTC

So the brief is opt-in only, confirmed by you, with a one-click unsubscribe that we act on promptly.

This is a plain-English summary of the rules as of 17 November 2026. It is not legal advice.

RefSources

  1. UK Government. The Privacy and Electronic Communications (EC Directive) Regulations 2003, regulation 22. legislation.gov.uk. www.legislation.gov.uk/uksi/2003/2426/regulation/22
  2. Australian Communications and Media Authority. Avoid sending spam. ACMA guidance on the Spam Act 2003. www.acma.gov.au/avoid-sending-spam
  3. US Federal Trade Commission. CAN-SPAM Act: A Compliance Guide for Business. FTC business guidance. www.ftc.gov/business-guidance/resources/can-spam-act-complia…
  4. Levine J, Herkula T. Signaling One-Click Functionality for List Email Headers. RFC 8058, IETF, 2017. www.rfc-editor.org/rfc/rfc8058
  5. Google. Email sender guidelines. Google Workspace Admin Help. support.google.com/a/answer/81126

Plain-English summary of public sources, not legal or medical advice. Last checked 17 Nov 2026.

Questions

Is The 6:00 brief free?

Yes. It costs nothing and you do not need an account to receive it.

Will signing up get me sales emails?

The brief itself never carries prices, offers or store links. New readers also get one separate note about how membership works, and can stop it without leaving the brief.

How do I unsubscribe?

Click the unsubscribe link at the bottom of any email. It is one click, and we stop promptly.

Can I send a question for the brief?

Yes, through the contact page. Reader questions are answered by 6AM Research; we cannot answer personal health questions.

Will you share my email address?

Only with the service providers that run the site and send the brief for us, under contract and only for that purpose. We do not sell personal information. The privacy policy has the details.

Evidence before hype.

One email a week: new research explained and regulatory changes. No prices, no hype.

Get the 6:00 brief

Free. Unsubscribe any time.

Written by 6AM Research. Drafted from primary sources; every claim links to its source, and the page is dated. Editorial policy · How we check every page
Every batch has a public lab report. Look it up by the batch number on the vial. Batch COA lookup